Milder clinical hyperimmunoglobulin e syndrome phenotype is associated with partial interleukin-17 deficiency

Clinical and Experimental Immunology

Volumn 159, Issue 1, 2010, Pages 57-64

  Van De Veerdonk, F L ^a   Marijnissen, R ^a   Joosten, L A B ^a   Kullberg, B J ^a   Drenth, J P H ^a   Netea, M G ^a   Van Der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C. albicans; HIES; IL 17; S. aureus; STAT3

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 17; STAT3 PROTEIN;

ADULT; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN CELL; HYPER IGE SYNDROME; INTERLEUKIN 17 DEFICIENCY; MALE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TH17 CELL;

ADULT; CANDIDA ALBICANS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; JOB'S SYNDROME; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PEDIGREE; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTE SUBSETS;

EID: 70749128673     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04043.x     Document Type: Article

References (27)

1. Davis SD, Schaller J, Wedgwood RJ. Job's syndrome: recurrent 'cold' staphylococcal abcesses. Lancet 1966 1 : 1013 1015.
2. Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972 49 : 59 70.
3. Grimbacher B, Holland SM, Gallin JI et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N Engl J Med 1999 340 : 692 702.
4. Minegishi Y, Saito M, Tsuchiya S et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007 448 : 1058 1062.
5. Holland SM, DeLeo FR, Elloumi HZ et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007 357 : 1608 1619.
6. Nishihara M, Ogura H, Ueda N et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 2007 19 : 695 702.
7. Yang XO, Panopoulos AD, Nurieva R et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007 282 : 9358 9363.
8. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008 28 : 454 467.
9. Milner JD, Brenchley JM, Laurence A et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008 452 : 773 776.
10. Ma CS, Chew GY, Simpson N et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008 205 : 1551 1557.
11. de Beaucoudrey L, Puel A, Filipe-Santos O et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008 205 : 1543 1550.
12. Mezger M, Kneitz S, Wozniok I, Kurzai O, Einsele H, Loeffler J. Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes. J Infect Dis 2008 197 : 924 931.
13. Netea MG, Schneeberger PM, de Vries E, Kullberg BJ, van der Meer JW, Koolen MI. Th1/Th2 cytokine imbalance in a family with hyper-IgE syndrome. Neth J Med 2002 60 : 349 353.
14. Lehrer RI, Cline MJ. Interaction of Candida albicans with human leukocytes and serum. J Bacteriol 1969 98 : 996 1004.
15. van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 2005 73 : 7458 7464.
16. Netea MG, Gow NA, Munro CA et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006 116 : 1642 1650. Epub 18 May 2006.
17. Netea MG, Kullberg BJ, van der Meer JW. Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome. Eur J Clin Invest 2005 35 : 718 721.
18. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009 5 : 329 340.
19. Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr Opin Infect Dis 2002 15 : 143 147.
20. Eyerich K, Foerster S, Rombold S et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 2008 128 : 2640 2645.
21. Renner ED, Rylaarsdam S, Anover-Sombke S et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 2008 122 : 181 187.
22. Shirafuji Y, Matsuura H, Sato A, Kanzaki H, Katayama H, Arata J. Hyperimmunoglobulin E syndrome: a sign of Th1/Th2 imbalance. Eur J Dermatol 1999 9 : 129 131.
23. Vargas L, Patino PJ, Rodriguez MF et al. Increase in granulocyte- macrophage-colony-stimulating factor secretion and the respiratory burst with decreased l-selectin expression in hyper-IgE syndrome patients. Ann Allergy Asthma Immunol 1999 83 : 245 251.
24. Billiau A. Interferon-γ: biology and role in pathogesis. Adv Immunol 1996 61 : 61 130.
25. Hubel K, Dale DC, Liles WC. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J Infect Dis 2002 185 : 1490 1501.
26. Jeppson JD, Jaffe HS, Hill HR. Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia. J Pediatr 1991 118 : 383 387.
27. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007 8 : 942 949.